Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

MRNA holding history

Moderna, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MRNA overviewAll 13F holders of MRNAFull Q2 2026 holdings

Shares (Q2 2026)
4,463,211
Value
$312.6M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of MRNA by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,463,211$312.6M<0.1%+55,304+1.3%AddedHolders
Q1 20264,407,907$223.9M<0.1%+321,141+7.9%AddedHolders
Q4 20254,086,766$120.5M<0.1%−714,781−14.9%ReducedHolders
Q3 20254,801,547$124.0M<0.1%+859,315+21.8%AddedHolders
Q2 20253,942,232$108.8M<0.1%−2,435,305−38.2%ReducedHolders
Q1 20256,377,537$180.8M<0.1%+1,304,166+25.7%AddedHolders
Q4 20245,073,371$211.0M<0.1%+2,804,243+123.6%AddedHolders
Q3 20242,269,128$151.6M<0.1%+1,187,367+109.8%AddedHolders
Q2 20241,081,761$128.5M<0.1%+64,573+6.3%AddedHolders
Q1 20241,017,188$108.4M<0.1%+143,919+16.5%AddedHolders
Q4 2023873,269$86.8M<0.1%−119,743−12.1%ReducedHolders
Q3 2023993,012$102.6M<0.1%+256,471+34.8%AddedHolders
Q2 2023736,541$89.5M<0.1%+182,377+32.9%AddedHolders
Q1 2023554,164$85.1M<0.1%+104,588+23.3%AddedHolders
Q4 2022449,576$80.8M<0.1%+137,479+44.1%AddedHolders
Q3 2022312,097$36.9M<0.1%−115,255−27.0%ReducedHolders
Q2 2022427,352$61.0M<0.1%+62,194+17.0%AddedHolders
Q1 2022365,158$62.9M<0.1%−346,161−48.7%ReducedHolders
Q4 2021711,319$180.7M0.1%−51,687−6.8%ReducedHolders
Q3 2021763,006$293.6M0.1%+348,592+84.1%AddedHolders
Q2 2021414,414$97.4M<0.1%−51,919−11.1%ReducedHolders
Q1 2021466,333$61.1M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.